Status:
UNKNOWN
Vienna Versus SARS-CoV-2 Virus Study
Lead Sponsor:
Medical University of Vienna
Conditions:
SARS-CoV-2
COVID-19
Eligibility:
All Genders
Brief Summary
This study examines the seroprevalence against SARS-CoV-2 in health care workers and patients at the Vienna General Hospital.
Detailed Description
This study consists of 2 parts: a longitudinal study enrolling 3,000 health care professionals at the Vienna General Hospital testing their antibody status 6 times over a period of 12 months (Cohort A...
Eligibility Criteria
Inclusion
- Cohort A:
- Inclusion criteria:
- Physicians
- Nursing staff
- Midwives
- Medical-technical assistants (including medical, therapeutic and diagnostic healthcare staff, and medical and nursing assistants)
- Administrative personnel with patient contact
Exclusion
- Not employed at the Medical University of Vienna or the Vienna General Hospital
- No signed informed consent
- Cohort B:
- Inclusion Criteria:
- ● Patients with available residual serum samples
Key Trial Info
Start Date :
May 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 27 2021
Estimated Enrollment :
12000 Patients enrolled
Trial Details
Trial ID
NCT04407429
Start Date
May 27 2020
End Date
June 27 2021
Last Update
May 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Austria, 1090